490 related articles for article (PubMed ID: 12814994)
21. Environmental tobacco smoke and lung cancer in nonsmokers: does time since exposure play a role?
Nyberg F; Agrenius V; Svartengren K; Svensson C; Pershagen G
Epidemiology; 1998 May; 9(3):301-8. PubMed ID: 9583423
[TBL] [Abstract][Full Text] [Related]
22. Molecular epidemiology of bladder cancer.
Vineis P; Martone T
Ann Ist Super Sanita; 1996; 32(1):21-7. PubMed ID: 8967722
[TBL] [Abstract][Full Text] [Related]
23. Acetylation phenotype, carcinogen-hemoglobin adducts, and cigarette smoking.
Vineis P; Caporaso N; Tannenbaum SR; Skipper PL; Glogowski J; Bartsch H; Coda M; Talaska G; Kadlubar F
Cancer Res; 1990 May; 50(10):3002-4. PubMed ID: 2334904
[TBL] [Abstract][Full Text] [Related]
24. Polymorphisms of the DNA repair genes XRCC1, XRCC3, XPD, interaction with environmental exposures, and bladder cancer risk in a case-control study in northern Italy.
Shen M; Hung RJ; Brennan P; Malaveille C; Donato F; Placidi D; Carta A; Hautefeuille A; Boffetta P; Porru S
Cancer Epidemiol Biomarkers Prev; 2003 Nov; 12(11 Pt 1):1234-40. PubMed ID: 14652287
[TBL] [Abstract][Full Text] [Related]
25. Biomonitoring of smoke constituents: exposure to 4-aminobiphenyl and 4-aminobiphenyl hemoglobin adduct levels in nonsmokers and smokers.
Schorp MK; Leyden DE
Inhal Toxicol; 2010 Aug; 22(9):725-37. PubMed ID: 20433335
[TBL] [Abstract][Full Text] [Related]
26. Hemoglobin-carcinogen adducts as molecular biomarkers in epidemiology.
Tannenbaum SR
Princess Takamatsu Symp; 1990; 21():351-60. PubMed ID: 2134688
[TBL] [Abstract][Full Text] [Related]
27. Effects of timing and type of tobacco in cigarette-induced bladder cancer.
Vineis P; Esteve J; Hartge P; Hoover R; Silverman DT; Terracini B
Cancer Res; 1988 Jul; 48(13):3849-52. PubMed ID: 3378220
[TBL] [Abstract][Full Text] [Related]
28. Carotenoids/vitamin C and smoking-related bladder cancer.
Castelao JE; Yuan JM; Gago-Dominguez M; Skipper PL; Tannenbaum SR; Chan KK; Watson MA; Bell DA; Coetzee GA; Ross RK; Yu MC
Int J Cancer; 2004 Jun; 110(3):417-23. PubMed ID: 15095308
[TBL] [Abstract][Full Text] [Related]
29. Smoking and bladder cancer in Spain: effects of tobacco type, timing, environmental tobacco smoke, and gender.
Samanic C; Kogevinas M; Dosemeci M; Malats N; Real FX; Garcia-Closas M; Serra C; Carrato A; García-Closas R; Sala M; Lloreta J; Tardón A; Rothman N; Silverman DT
Cancer Epidemiol Biomarkers Prev; 2006 Jul; 15(7):1348-54. PubMed ID: 16835335
[TBL] [Abstract][Full Text] [Related]
30. Black (air-cured) and blond (flue-cured) tobacco cancer risk. IV: Molecular dosimetry studies implicate aromatic amines as bladder carcinogens.
Bartsch H; Malaveille C; Friesen M; Kadlubar FF; Vineis P
Eur J Cancer; 1993; 29A(8):1199-207. PubMed ID: 8518034
[TBL] [Abstract][Full Text] [Related]
31. [Individual susceptibility to occupational carcinogens: the evidence from biomonitoring and molecular epidemiology studies].
Pavanello S; Clonfero E
G Ital Med Lav Ergon; 2004; 26(4):311-21. PubMed ID: 15584438
[TBL] [Abstract][Full Text] [Related]
32. Phenobarbital, drug metabolism, and human cancer.
Olsen JH; Wallin H; Boice JD; Rask K; Schulgen G; Fraumeni JF
Cancer Epidemiol Biomarkers Prev; 1993; 2(5):449-52. PubMed ID: 8220089
[TBL] [Abstract][Full Text] [Related]
33. Glutathione S-transferase M1 genotype affects aminobiphenyl-hemoglobin adduct levels in white, black and Asian smokers and nonsmokers.
Yu MC; Ross RK; Chan KK; Henderson BE; Skipper PL; Tannenbaum SR; Coetzee GA
Cancer Epidemiol Biomarkers Prev; 1995 Dec; 4(8):861-4. PubMed ID: 8634658
[TBL] [Abstract][Full Text] [Related]
34. Gender- and smoking-related bladder cancer risk.
Castelao JE; Yuan JM; Skipper PL; Tannenbaum SR; Gago-Dominguez M; Crowder JS; Ross RK; Yu MC
J Natl Cancer Inst; 2001 Apr; 93(7):538-45. PubMed ID: 11287448
[TBL] [Abstract][Full Text] [Related]
35. Interaction between environmental tobacco smoke and arsenic methylation ability on the risk of bladder cancer.
Chen YC; Su HJ; Guo YL; Houseman EA; Christiani DC
Cancer Causes Control; 2005 Mar; 16(2):75-81. PubMed ID: 15868449
[TBL] [Abstract][Full Text] [Related]
36. Levelling-off of the risk of lung and bladder cancer in heavy smokers: an analysis based on multicentric case-control studies and a metabolic interpretation.
Vineis P; Kogevinas M; Simonato L; Brennan P; Boffetta P
Mutat Res; 2000 Jul; 463(1):103-10. PubMed ID: 10928863
[TBL] [Abstract][Full Text] [Related]
37. Tobacco smoking and risk of bladder cancer.
Boffetta P
Scand J Urol Nephrol Suppl; 2008 Sep; (218):45-54. PubMed ID: 18815916
[TBL] [Abstract][Full Text] [Related]
38. Environmental tobacco smoke and breast cancer incidence.
Gammon MD; Eng SM; Teitelbaum SL; Britton JA; Kabat GC; Hatch M; Paykin AB; Neugut AI; Santella RM
Environ Res; 2004 Oct; 96(2):176-85. PubMed ID: 15325878
[TBL] [Abstract][Full Text] [Related]
39. GSTM1 and CYP1A1 polymorphisms, tobacco, air pollution, and lung cancer: a study in rural Thailand.
Pisani P; Srivatanakul P; Randerson-Moor J; Vipasrinimit S; Lalitwongsa S; Unpunyo P; Bashir S; Bishop DT
Cancer Epidemiol Biomarkers Prev; 2006 Apr; 15(4):667-74. PubMed ID: 16614107
[TBL] [Abstract][Full Text] [Related]
40. Tobacco smoking, coffee drinking, and occupation as risk factors for bladder cancer in Greece.
Rebelakos A; Trichopoulos D; Tzonou A; Zavitsanos X; Velonakis E; Trichopoulos A
J Natl Cancer Inst; 1985 Sep; 75(3):455-61. PubMed ID: 3861898
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
